The Short Answer
ZBH is incomplete and methodology-dependent under the current record. Orthopedic medical devices and surgical robotics are generally permissible activities. March 2026 debt/assets is 32.88%, close to the examined 33% boundary, and the filing does not provide a standalone gross interest-income numerator.
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-13.
7,471 / 22,721.6
424.2 / 22,721.6
2,152.8 / 22,721.6
- Financial
- Incomplete
- Overall
- Incomplete
Debt/assets is 32.88%, liquidity/assets 1.87% and receivables plus cash/assets 9.47%; the FTSE income input is unavailable.
- Financial
- Pass
- Overall
- Incomplete
Debt, liquidity and receivables-plus-cash are below the examined MSCI limits; the business and purification record remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
Debt and liquidity are below the examined Malaysia SAC limits, but missing gross income disclosure prevents a complete overall result.
- Financial
- Not calculated
- Overall
- Incomplete
No licensed historical market-cap series is stored.
Business-activity disclosure
Zimmer Biomet designs and sells orthopedic, trauma, extremity, dental and surgical-robotics medical devices. The core therapeutic activity is generally permissible, while product-level financing income and customer use remain qualitative topics.
Limitation: The filing does not provide a single gross interest-income numerator or a universally accepted prohibited-revenue numerator.
Purification
A standalone gross interest-income numerator is not disclosed in the filing, so no fixed purification percentage is asserted.
Inputs, assumptions and primary sources
- Amounts are USD millions from the unaudited March 31, 2026 Form 10-Q.
- Debt is the $1,175.9 million current portion plus $6,295.1 million long-term debt.
- Quarterly net sales are $2,086.7 million; the filing does not present a single gross interest-income numerator.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Business activity
Zimmer Biomet reports knee, hip, trauma, extremity, dental and surgical-robotics products. These are therapeutic technologies. The open items are the near-threshold debt ratio and missing gross-income disclosure, not a prohibited product category.
Bottom line
ZBH is generally permissible at the activity level but incomplete financially until the next filing supplies a gross interest-income input and confirms leverage.